| Not Yet Recruiting | Home Monitoring in eAMD Treatment Exudative Age-Related Macular Degeneration | — | 2026-03-01 |
| Not Yet Recruiting | Retinal Ganglion Cell Neuroprotection Under Prostaglandin Analogues Glaucoma | — | 2026-01-01 |
| Recruiting | Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients Diabetic Retinopathy, Diabetes Mellitus, Type 2, Diabetic Complication | — | 2025-11-24 |
| Recruiting | Analysis of DR Progression to Identify Risks and Need for Treatment Diabetic Retinopathy | — | 2025-11-03 |
| Recruiting | Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Ch Polypoidal Choroidal Vasculopathy | Phase 4 | 2025-08-06 |
| Completed | Evaluation of a Health Education Program for Type 2 Diabetes Patients Retinopathy, Diabetic | N/A | 2023-10-13 |
| Active Not Recruiting | Can the Risk for AMD be Modulated? Age-Related Macular Degeneration (ARMD) | N/A | 2023-06-26 |
| Active Not Recruiting | A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Stud Age Related Macular Degeneration, Intermediate AMD, Atrophy | — | 2023-05-04 |
| Completed | Diabetic Retinopathy Classification: ETDRS 7-fields vs Widefield Imaging (ClarusDR) Retinopathy, Diabetic | — | 2023-04-03 |
| Active Not Recruiting | Prediction of Progression of Retinal Ischemia in Diabetes Diabetic Retinopathy | — | 2022-12-02 |
| Active Not Recruiting | Retinal Ischemia Characterization in Diabetes - "RICHARD" Diabetic Retinopathy | — | 2022-03-30 |
| Completed | Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabete NPDR - Non Proliferative Diabetic Retinopathy, Diabetes Mellitus, Type 2, Retinal Disease | — | 2021-09-22 |
| Completed | Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration Age-related Macular Degeneration | N/A | 2021-06-01 |
| Completed | 10-year Progression of Diabetic Retinopathy: Identification of Signs and Surrogate Outcomes Diabetic Retinopathy | — | 2021-06-01 |
| Completed | Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2 NPDR - Non Proliferative Diabetic Retinopathy | N/A | 2018-10-30 |
| Completed | Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes Diabetic Retinopathy | — | 2016-12-01 |
| Completed | Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal Age-Related Macular Degeneration | — | 2016-07-01 |
| Completed | Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal A Polypoidal Choroidal Vasculopathy | Phase 4 | 2015-11-23 |
| Completed | Clinical Evaluation of Noninvasive OCT Angiography Using a Zeiss OCT Prototype to Compare to Fluorescein Angio Diabetic Retinopathy | — | 2015-09-01 |
| Active Not Recruiting | Characterization of Potential Biomarkers of Eye Disease and Vision Eye Disease | — | 2015-09-01 |
| Completed | A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients Diabetic Macular Edema | Phase 4 | 2014-10-01 |
| Completed | Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema Diabetic Macular Edema | — | 2014-08-01 |
| Completed | Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibi High Risk Proliferative Diabetic Retinopathy | Phase 2 / Phase 3 | 2014-04-01 |
| Completed | Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal An Diabetic Macular Edema | — | 2014-01-01 |
| Completed | Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) Glaucoma, Ocular Hypertension | Phase 4 | 2013-10-01 |
| Completed | Life Style and Food Habits Questionnaire in the Portuguese Population Aged 55 or More Age Related Macular Degeneration | — | 2012-12-01 |
| Completed | Biomarkers of Diabetic Retinopathy Progression Type 2 Diabetes Mellitus, Mild Nonproliferative Diabetic Retinopathy | — | 2012-11-01 |
| Completed | Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DI Type-2 Diabetes, Diabetic Retinopathy | — | 2012-01-01 |
| Completed | Evaluation of Blood-retinal Barrier Functional Alterations by Optical Coherence Tomography Diabetic Retinopathy | — | 2010-11-01 |
| Completed | Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 High Risk Proliferative Diabetic Retinopathy, Diabetes Mellitus Type I, Diabetes Mellitus Type II | Phase 2 | 2010-03-01 |
| Completed | Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy Type-2 Diabetic Retinopathy | — | 2010-03-01 |
| Completed | Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal Age-Related Macular Degeneration | — | 2009-08-01 |
| Completed | Phenotyping Diabetic Retinopathy Diabetic Retinopathy | — | 2009-01-01 |
| Completed | Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherenc Diabetic Retinopathy, Age-Related Macular Degeneration, Macular Edema | — | 2008-11-01 |
| Completed | Retinal Thickness Analysis Using Optical Coherence Tomography Diabetic Retinopathy | — | 2008-11-01 |
| Completed | Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function Age-Related Maculopathy, Diabetic Macular Edema | — | 2008-03-01 |
| Completed | Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema an Diabetic Retinopathy | — | 2007-09-01 |
| Completed | Characterization of Early Markers of Choroidal Neovascularization Age-related Macular Degeneration | — | 2005-12-01 |